SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-21-000140
Filing Date
2021-11-09
Accepted
2021-11-09 16:57:33
Documents
92
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20210930.htm   iXBRL 10-Q 2090672
2 EX-10.1 a2021q3bhvn10-qexhibit101.htm EX-10.1 1683230
3 EX-31.1 a2021q3bhvn10-qexhibit311.htm EX-31.1 10728
4 EX-31.2 a2021q3bhvn10-qexhibit312.htm EX-31.2 10942
5 EX-32.1 a2021q3bhvn10-qexhibit321.htm EX-32.1 7762
  Complete submission text file 0001689813-21-000140.txt   13098736

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210930.xsd EX-101.SCH 93152
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20210930_cal.xml EX-101.CAL 91805
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20210930_def.xml EX-101.DEF 477973
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210930_lab.xml EX-101.LAB 923492
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210930_pre.xml EX-101.PRE 677805
11 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210930_htm.xml XML 2081835
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 211393034
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences